SmarterDividends
RPRX

Royalty Pharma plc

RPRX

Healthcare · Stock · quarterly payer

Forward Yield

1.71%

Annual Dividend

$0.94

Payout Ratio

47%

5-Yr Growth

8.0%

Ex-Date

May 15, 2026

Frequency

Quarterly

RPRX Dividend Safety Score

76/ 100
Grade B

Safe

Dividend-growth streak4 consecutive years of growth
Cut historyNever cut its dividend on record
Earnings payout coverage47% of earnings paid out
Balance-sheet strengthDebt/equity of 0.90
Yield vs its historyYield in line with its history

SmarterDividends' proprietary score, backtested against which dividends were actually cut over 15+ years (0.78 AUC). It blends a validated cut-risk model (growth streak, cut history) with current payout, cash-flow and debt. Higher is safer · not investment advice.

Dividend Growth

Total dividends per share by year

Is RPRX a good dividend stock?

Yes

Royalty Pharma plc (RPRX) pays a quarterly dividend yielding 1.71% ($0.94/yr), with 5 years of growth and a dividend-safety grade of B. It scores well across payout coverage, growth history and safety — a dependable income holding.

Advantages

  • Never cut its dividend on record
  • Comfortable payout ratio (47%)
  • Strong 8.0% 5-yr dividend growth

Risks

  • Single-stock concentration risk — diversify

Key Data

Dividend Yield
1.71%
Payout Ratio
47%
Annual Dividend
$0.94
5-Yr Avg Growth
8.0%
Ex-Dividend Date
May 15, 2026
Years of Growth
5
Frequency
quarterly
Beta
0.42
Market Cap
$31.7B
P/E Ratio
29.0
5-Yr Total Return
35%
52-Week Range
$33.37 – $56.07
Dividend Safety
B · 76/100
Ever Cut?
No
RPRX ex-dividend date & scheduleNext ex-date May 15, 2026 · full ex-dividend historyView →

Frequently Asked Questions

Income Calculator

At $0.94 / yr per share

Per payment (quarterly)$23.50
Annual$94.00
Monthly avg$7.83